市場調査レポート

商品コード

1762541

凍結乾燥サービス市場：業界動向と世界の予測 - 凍結乾燥される生物製剤タイプ別、一次包装システムタイプ別、主要地域別

Lyophilization Services Market : Industry Trends and Global Forecasts - Distribution by Type of Biologic Lyophilized, Type of Primary Packaging System and Key Geographies

出版日: 2025年07月04日
発行: Roots Analysis
ページ情報: 英文 225 Pages
納期: 即日から翌営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,799 705,884円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (One-Location Site License)

USD 6,999 1,029,482円

レポートPDFを同一所在地における特定事業ユニットに属する全ての方にてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Department License)

USD 10,599 1,559,006円

レポートPDFを部署単位で12名様までご利用いただけるライセンスです。同一部署内であれば、地理的に同じ地点に存在する必要はありません。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 17,999 2,647,472円

レポートPDFを同社の国内外拠点における全ての方にてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=147.09円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

凍結乾燥サービス市場：概要

世界の凍結乾燥サービスの市場規模は、2035年までの予測期間中に6.3%のCAGRで拡大し、現在の26億米ドルから2035年までに49億米ドルに成長すると予測されています。

市場セグメンテーションでは、市場規模および機会分析を以下のパラメータで区分しています：

凍結乾燥される生物製剤タイプ

抗体
細胞・遺伝子治療薬
ワクチン
その他の生物製剤

一次包装システムタイプ

バイアル
シリンジ
カートリッジ
アンプル
その他

主要地域

北米
欧州
アジア太平洋
ラテンアメリカ
中東・北アフリカ

凍結乾燥サービス市場：成長と動向

凍結乾燥は医薬品の安定化技術であり、物質の化学的性質を保持したまま凍結乾燥によって水などの余分な溶媒を除去します。特に、凍結乾燥には、実験室用凍結乾燥機、非滅菌凍結乾燥機、滅菌可能凍結乾燥機などの特殊な機器が使用されます。長年にわたり、凍結乾燥が、より長く商業的に実行可能な保存期間を達成し、安定した乾燥した生物製剤製剤を可能にする好ましいアプローチとして浮上してきたことは注目に値します。しかしながら、バイオシミラーや新規の生物製剤のパイプラインが急速に成長していること、生物製剤の凍結乾燥に関連する課題が存在することから、利害関係者はこの領域で学際的な専門知識を提供するサービスプロバイダーへの依存を強めています。

加えて、いくつかの市場リーダーは、作業効率を改善し、乾燥プロセス中のプロセス制御を達成するために、凍結乾燥技術の進歩と革新のための調査を加速しています。その結果、プロセス全体の生産性と効率が向上しています。例えば、連続凍結乾燥システムや自動凍結乾燥システムのような最新技術は、これらの技術を採用し、顧客のカスタマイズされた凍結乾燥サービスの要件を満たすことを産業リーダーに促しています。

凍結乾燥サービス市場：主要インサイト

当レポートでは、凍結乾燥サービス市場の現状を調査し、潜在的な成長機会を特定しています。主な調査結果は以下の通りです：

現在、105社以上のサービスプロバイダーが、タンパク質、抗体、核酸、細胞/遺伝子療法を含む様々なバイオ治療薬の凍結乾燥サービスを提供するために必要な専門知識を持っていると主張しています。
現在の市場情勢は非常に断片化されており、新規参入企業と主要地域に拠点を置く既存企業の両方が存在しています。
利害関係者はそれぞれの専門知識を活かして、様々な規模の凍結乾燥サービスを提供しています。さらに、バイアルは生物製剤を保管するための一次包装システムとして好ましい選択肢として浮上しています。

進化する規制状況をうまく乗り切るため、サービスプロバイダーは顧客のカスタマイズされた要望に応えるべくポートフォリオを拡大しています。
この領域への関心の高まりは、提携活動の増加からも明らかであり、事実、生物製剤の凍結乾燥に関連する提携は過去2年間で最多となっています。
需要の高まりに対応するため、多くの企業が新たな施設の設立や既存能力の拡張など、サービスポートフォリオの強化に向けた拡大策を講じています。
市場は2035年まで安定した速度で成長すると予想され、予測される機会は様々な種類の生物学的製剤の凍結乾燥、一次包装システム、地理的地域にうまく分配されると予測されます。

凍結乾燥サービス市場：主要セグメント

凍結乾燥される生物製剤タイプ別では、市場は抗体、細胞・遺伝子治療、ワクチン、その他の生物製剤に区分されます。現在、抗体分野が世界の凍結乾燥サービス市場で最大のシェアを占めています。この動向は、無数の疾患の治療のための標的特異的薬剤の需要の増加により、今後数年間も変わらないと思われます。

一次包装システムタイプ別では、市場はバイアル、シリンジ、カートリッジ、アンプル、その他に区分されます。現在のところ、バイアルセグメントが世界の凍結乾燥サービス市場で最大のシェアを占めています。しかし、自動ドラッグデリバリー注射やプレフィルドシリンジに対する需要の高まりにより、シリンジ市場は予測期間中により高いCAGRで成長すると予想されます。

主要地域別に見ると、市場は北米、欧州、アジア太平洋、中南米、中東・北アフリカ、ラテンアメリカに区分されます。現在、北米が世界の凍結乾燥サービス市場を独占し、最大の収益シェアを占めています。さらに、アジア太平洋の市場は、今後より高いCAGRで成長する可能性が高いです。

凍結乾燥サービス市場における参入企業例

Baxter BioPharma Solutions
CordenPharma
Coriolis Pharma
Curia
Emergent BioSolutions
LSNE Contract Manufacturing
Lyophilization Technology
Northway Biotech
ProJect Pharmaceutics
Vetter Pharma

章の概要
予測調査手法と主要な前提条件
生物製剤向け凍結乾燥サービスの世界市場（2035年まで）
生物製剤の凍結乾燥サービス市場：凍結乾燥される生物製剤タイプ別
生物製剤の凍結乾燥サービス市場：一次包装システムタイプ別
生物製剤の凍結乾燥サービス市場：地域別

第15章結論

第16章エグゼクティブ洞察

第17章付録1：表形式データ

第18章付録2：企業・団体一覧

図表

List of Tables

Table 4.1 List of Lyophilization Service Providers for Biopharmaceuticals
Table 5.1 Benchmark Analysis: Information on Peer Groups
Table 6.1 Leading Lyophilization Service Providers for Biopharmaceuticals in North America
Table 6.2 Baxter BioPharma Solutions: Company Snapshot
Table 6.3 Baxter BioPharma Solutions: Lyophilization Service Offerings for Biopharmaceuticals
Table 6.4 Baxter BioPharma Solutions: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 6.5 Baxter BioPharma Solutions: Recent Developments and Future Outlook
Table 6.6 Curia: Company Snapshot
Table 6.7 Curia: Lyophilization Service Offerings for Biopharmaceuticals
Table 6.8 Curia: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 6.9 Curia: Recent Developments and Future Outlook
Table 6.10 Emergent BioSolutions: Company Snapshot
Table 6.11 Emergent BioSolutions: Lyophilization Service Offerings for Biopharmaceuticals
Table 6.12 Emergent BioSolutions: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 6.13 Emergent BioSolutions: Recent Developments and Future Outlook
Table 6.14 LSNE Contract Manufacturing: Company Snapshot
Table 6.15 LSNE Contract Manufacturing: Lyophilization Service Offerings for Biopharmaceuticals
Table 6.16 LSNE Contract Manufacturing: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 6.17 LSNE Contract Manufacturing: Recent Developments and Future Outlook
Table 6.18 Lyophilization Technology: Company Snapshot
Table 6.19 Lyophilization Technology: Lyophilization Service Offerings for Biopharmaceuticals
Table 6.20 Lyophilization Technology: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 6.21 Lyophilization Technology: Recent Developments and Future Outlook
Table 7.1 Leading Lyophilization Service Providers for Biopharmaceuticals in Europe
Table 7.2 CordenPharma: Company Snapshot
Table 7.3 CordenPharma: Lyophilization Service Offerings for Biopharmaceuticals
Table 7.4 CordenPharma: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 7.5 CordenPharma: Recent Developments and Future Outlook
Table 7.6 Coriolis Pharma: Company Snapshot
Table 7.7 Coriolis Pharma: Lyophilization Service Offerings for Biopharmaceuticals
Table 7.8 Coriolis Pharma: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 7.9 Coriolis Pharma: Recent Developments and Future Outlook
Table 7.10 Northway Biotech: Company Snapshot
Table 7.11 Northway Biotech: Lyophilization Service Offerings for Biopharmaceuticals
Table 7.12 Northway Biotech: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 7.13 Northway Biotech: Recent Developments and Future Outlook
Table 7.14 ProJect Pharmaceutics: Company Snapshot
Table 7.15 ProJect Pharmaceutics: Lyophilization Service Offerings for Biopharmaceuticals
Table 7.16 ProJect Pharmaceutics: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 7.17 Vetter Pharma: Company Snapshot
Table 7.18 Vetter Pharma: Lyophilization Service Offerings for Biopharmaceuticals
Table 7.19 Vetter Pharma: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 7.20 Vetter Pharma: Recent Developments and Future Outlook
Table 8.1 Leading Lyophilization Service Providers for Biopharmaceuticals in Asia Pacific
Table 8.2 BioZed Engineering: Company Snapshot
Table 8.3 BioZed Engineering: Lyophilization Service Offerings for Biopharmaceuticals
Table 8.4 BioZed Engineering: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 8.5 BioZed Engineering: Recent Developments and Future Outlook
Table 8.6 CinnaGen: Company Snapshot
Table 8.7 CinnaGen: Lyophilization Service Offerings for Biopharmaceuticals
Table 8.8 CinnaGen: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 8.9 CinnaGen: Recent Developments and Future Outlook
Table 8.10 MabPlex: Company Snapshot
Table 8.11 MabPlex: Lyophilization Service Offerings for Biopharmaceuticals
Table 8.12 MabPlex: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 8.13 MabPlex: Recent Developments and Future Outlook
Table 8.14 Samsung Biologics: Company Snapshot
Table 8.15 Samsung Biologics: Lyophilization Service Offerings for Biopharmaceuticals
Table 8.16 Samsung Biologics: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 8.17 Samsung Biologics: Recent Developments and Future Outlook
Table 8.18 WuXi Biologics: Company Snapshot
Table 8.19 WuXi Biologics: Lyophilization Service Offerings for Biopharmaceuticals
Table 8.20 WuXi Biologics: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 8.21 WuXi Biologics: Recent Developments and Future Outlook
Table 9.1 Lyophilization Services for Biopharmaceuticals: List of Partnerships and Collaborations, Since 2018
Table 10.1 Lyophilization Services for Biopharmaceuticals: List of Recent Expansions, Since 2018
Table 11.1 Lyophilization Services Market for Biopharmaceuticals: List of Respondents
Table 12.1 Lyophilization Cycle Development and Optimization: List of Service Providers
Table 12.2 BSP Pharmaceuticals: Company Snapshot
Table 12.3 CuriRx: Company Snapshot
Table 12.4 GILYOS: Company Snapshot
Table 12.5 Pierre Fabre: Company Snapshot
Table 12.6 Singota Solutions: Company Snapshot
Table 13.1 Spray Drying for Biopharmaceuticals: List of Service Providers
Table 13.2 Comparison of Lyophilization and Spray Drying Process
Table 16.1 Pharmaceutical International: Company Snapshot
Table 16.2 Curia: Company Snapshot
Table 16.3 Emergent BioSolutions: Company Snapshot
Table 16.4 Liof Pharma: Company Snapshot
Table 16.5 Vibalogics: Company Snapshot
Table 16.6 Samsung Biologics: Company Snapshot
Table 16.7 Bioserv: Company Snapshot
Table 16.8 Symbiosis Pharmaceutical Services: Company Snapshot
Table 16.9 Patheon: Company Snapshot
Table 16.10 Baxter BioPharma Solutions: Company Snapshot
Table 17.1 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Year of Establishment
Table 17.2 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Company Size
Table 17.3 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Location of Headquarters
Table 17.4 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Scale of Operation
Table 17.5 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Regulatory Certification / Accreditation
Table 17.6 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Type of Biologic Lyophilized
Table 17.7 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Process of Lyophilization
Table 17.8 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Type of Primary Packaging System
Table 17.9 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Additional Services Offered
Table 17.10 Benchmark Analysis: Asia Pacific and Rest of the World, Peer Group VII
Table 17.11 Benchmark Analysis: Asia Pacific and Rest of the World, Peer Group VIII
Table 17.12 Partnerships and Collaborations: Cumulative Year-wise Trend, Since 2018
Table 17.13 Partnerships and Collaborations: Distribution by Type of Partnership
Table 17.14 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 17.15 Most Active Players: Distribution by Number of Partnerships
Table 17.16 Partnerships and Collaborations: Intercontinental and Intracontinental Deals
Table 17.17 Partnerships and Collaborations: International and Local Deals
Table 17.18 Recent Expansions: Cumulative Year-wise Trend, Since 2018
Table 17.19 Recent Expansions: Distribution by Type of Expansion
Table 17.20 Recent Expansions: Distribution by Year and Type of Expansion
Table 17.21 Recent Expansions: Distribution by Company Size and Location of Headquarters
Table 17.22 Recent Expansions: Distribution by Location of Expanded Facility
Table 17.23 Recent Expansions: Distribution by Location of Expanded Facility and Type of Expansion
Table 17.24 Active Players: Distribution by Number of Recent Expansions
Table 17.25 Recent Expansions: Distribution by Geography
Table 17.26 Survey Analysis: Distribution by Geographical Location of Respondents
Table 17.27 Survey Analysis: Distribution by Seniority Levels of Respondents
Table 17.28 Survey Analysis: Distribution by Type of Biologic Lyophilized
Table 17.29 Survey Analysis: Distribution by Type of Primary Packaging System
Table 17.30 Survey Analysis: Distribution by Scale of Operation
Table 17.31 Survey Analysis: Distribution by Additional Services Offered
Table 17.32 Survey Analysis: Distribution by Location of Lyophilization Facility
Table 17.33 Survey Analysis: Distribution by Share of Lyophilization Operations Outsourced
Table 17.34 Survey Analysis: Distribution by Likely Current Market Size
Table 17.35 Survey Analysis: Distribution of Likely Market Share by Type of Biologic Lyophilized
Table 17.36 Survey Analysis: Distribution Likely Market Share by Geography
Table 17.37 Lyophilization Cycle Development and Optimization Service Providers: Distribution by Company Size
Table 17.38 Lyophilization Cycle Development and Optimization Service Providers: Distribution by Location of Headquarters
Table 17.39 Lyophilization Cycle Development and Optimization Service Providers: Distribution by Type of Service Offered
Table 17.40 Global Lyophilization Services Market for Biopharmaceuticals, Till 2035 (USD Billion)
Table 17.41 Lyophilization Services Market for Biopharmaceuticals: Distribution by Type of Biologic Lyophilized (USD Billion)
Table 17.42 Lyophilization Services Market for Antibodies, Till 2035 (USD Billion)
Table 17.43 Lyophilization Services Market for Cell and Gene Therapies, Till 2035 (USD Billion)
Table 17.44 Lyophilization Services Market for Vaccines, Till 2035 (USD Billion)
Table 17.45 Lyophilization Services Market for Other Biologics, Till 2035 (USD Billion)
Table 17.46 Lyophilization Services Market for Biopharmaceuticals: Distribution by Type of Primary Packaging System (USD Billion)
Table 17.47 Lyophilization Services Market for Biopharmaceuticals Stored in Vials, Till 2035 (USD Billion)
Table 17.48 Lyophilization Services Market for Biopharmaceuticals Stored in Syringes, Till 2035 (USD Billion)
Table 17.49 Lyophilization Services Market for Biopharmaceuticals Stored in Cartridges, Till 2035 (USD Billion)
Table 17.50 Lyophilization Services Market for Biopharmaceuticals Stored in Ampoules, Till 2035 (USD Billion)
Table 17.51 Lyophilization Services Market for Biopharmaceuticals Stored in Other Primary Packaging Systems, Till 2035 (USD Billion)
Table 17.52 Lyophilization Services Market for Biopharmaceuticals: Distribution by Geography (USD Billion)
Table 17.53 Lyophilization Services Market for Biopharmaceuticals in North America, Till 2035 (USD Billion)
Table 17.54 Lyophilization Services Market for Biopharmaceuticals in Europe, Till 2035 (USD Billion)
Table 17.55 Lyophilization Services Market for Biopharmaceuticals in Asia Pacific, Till 2035 (USD Billion)
Table 17.56 Lyophilization Services Market for Biopharmaceuticals in Middle East and North Africa, Till 2035 (USD Billion)
Table 17.57 Lyophilization Services Market for Biopharmaceuticals in Latin America, Till 2035 (USD Billion)
Table 17.58 Lyophilization Services Market for Biopharmaceuticals in Rest of the World, Till 2035 (USD Billion)

List of Figures

Figure 2.1 Executive Summary: Overall Market Landscape
Figure 2.2 Executive Summary: Partnerships and Collaborations
Figure 2.3 Executive Summary: Recent Expansions
Figure 2.4 Executive Summary: Survey Analysis
Figure 2.5 Executive Summary: Market Forecast
Figure 3.1 Historical Evolution of Lyophilization
Figure 3.2 Phase Diagram of Water
Figure 3.3 Sublimation of Ice Crystals
Figure 3.4 Key Steps Involved in Formulation and Filling of Biopharmaceuticals
Figure 3.5 Key Components of Lyophilizer
Figure 4.1 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Year of Establishment
Figure 4.2 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Company Size
Figure 4.3 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Location of Headquarters
Figure 4.4 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Scale of Operation
Figure 4.5 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Regulatory Certification / Accreditation
Figure 4.6 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Type of Biologic Lyophilized
Figure 4.7 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Process of Lyophilization
Figure 4.8 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Type of Primary Packaging System
Figure 4.9 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Additional Services Offered
Figure 5.1 Benchmark Analysis: Distribution by Company Size
Figure 5.2 Benchmark Analysis: North America (Peer Group I)
Figure 5.3 Benchmark Analysis: North America (Peer Group II)
Figure 5.4 Benchmark Analysis: North America (Peer Group III)
Figure 5.5 Benchmark Analysis: Europe (Peer Group IV)
Figure 5.6 Benchmark Analysis: Europe (Peer Group V)
Figure 5.7 Benchmark Analysis: Europe (Peer Group VI)
Figure 5.8 Benchmark Analysis: Asia Pacific and Rest of the World (Peer Group VII)
Figure 5.9 Benchmark Analysis: Asia Pacific and Rest of the World (Peer Group VIII)
Figure 9.1 Partnerships and Collaborations: Cumulative Year-wise Trend, Since 2018
Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 9.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 9.4 Most Active Players: Distribution by Number of Partnerships
Figure 9.5 Partnerships and Collaborations: Intercontinental and Intracontinental Deals
Figure 9.6 Partnerships and Collaborations: International and Local Deals
Figure 10.1 Recent Expansions: Cumulative Year-wise Trend, Since 2018
Figure 10.2 Recent Expansions: Distribution by Type of Expansion
Figure 10.3 Recent Expansions: Distribution by Year and Type of Expansion
Figure 10.4 Recent Expansions: Distribution by Company Size and Location of Headquarters
Figure 10.5 Recent Expansions: Distribution by Location of Expanded Facility
Figure 10.6 Recent Expansions: Distribution by Location of Expanded Facility and Type of Expansion
Figure 10.7 Active Players: Distribution by Number of Recent Expansions
Figure 10.8 Recent Expansions: Distribution by Geography
Figure 11.1 Survey Analysis: Distribution by Geographical Location of Respondents
Figure 11.2 Survey Analysis: Distribution by Seniority Levels of Respondents
Figure 11.3 Survey Analysis: Distribution by Type of Biologic Lyophilized
Figure 11.4 Survey Analysis: Distribution by Type of Primary Packaging System
Figure 11.5 Survey Analysis: Distribution by Scale of Operation
Figure 11.6 Survey Analysis: Distribution by Additional Services Offered
Figure 11.7 Survey Analysis: Distribution by Location of Lyophilization Facility
Figure 11.8 Survey Analysis: Distribution by Share of Lyophilization Operations Outsourced
Figure 11.9 Survey Analysis: Distribution by Likely Current Market Size
Figure 11.10 Survey Analysis: Distribution of Likely Market Share by Type of Biologic Lyophilized
Figure 11.11 Survey Analysis: Distribution of Likely Market Share by Geography
Figure 12.1 Lyophilization Cycle Development and Optimization Service Providers: Distribution by Company Size
Figure 12.2 Lyophilization Cycle Development and Optimization Service Providers: Distribution by Location of Headquarters
Figure 12.3 Lyophilization Cycle Development and Optimization Service Providers: Distribution by Type of Service Offered
Figure 13.1 Key Steps Involved in Spray Drying Process
Figure 14.1 Global Lyophilization Services Market for Biopharmaceuticals, Till 2035 (USD Billion)
Figure 14.2 Lyophilization Services Market for Biopharmaceuticals: Distribution by Type of Biologic Lyophilized, (USD Billion)
Figure 14.3 Lyophilization Services Market for Antibodies, Till 2035 (USD Billion)
Figure 14.4 Lyophilization Services Market for Cell and Gene Therapies, Till 2035 (USD Billion)
Figure 14.5 Lyophilization Services Market for Vaccines, Till 2035 (USD Billion)
Figure 14.6 Lyophilization Services Market for Other Biologics, Till 2035 (USD Billion)
Figure 14.7 Lyophilization Services Market for Biopharmaceuticals: Distribution by Type of Primary Packaging System, (USD Billion)
Figure 14.8 Lyophilization Services Market for Biopharmaceuticals Stored in Vials, Till 2035 (USD Billion)
Figure 14.9 Lyophilization Services Market for Biopharmaceuticals Stored in Syringes, Till 2035 (USD Billion)
Figure 14.10 Lyophilization Services Market for Biopharmaceuticals Stored in Cartridges, Till 2035 (USD Billion)
Figure 14.11 Lyophilization Services Market for Biopharmaceuticals Stored in Ampoules, Till 2035 (USD Billion)
Figure 14.12 Lyophilization Services Market for Biopharmaceuticals Stored in Other Primary Packaging Systems, Till 2035 (USD Billion)
Figure 14.13 Lyophilization Services Market for Biopharmaceuticals: Distribution by Geography, (USD Billion)
Figure 14.14 Lyophilization Services Market for Biopharmaceuticals in North America, Till 2035 (USD Billion)
Figure 14.15 Lyophilization Services Market for Biopharmaceuticals in Europe, Till 2035 (USD Billion)
Figure 14.16 Lyophilization Services Market for Biopharmaceuticals in Asia Pacific, Till 2035 (USD Billion)
Figure 14.17 Lyophilization Services Market for Biopharmaceuticals in Middle East and North Africa, Till 2035 (USD Billion)
Figure 14.18 Lyophilization Services Market for Biopharmaceuticals in Latin America, Till 2035 (USD Billion)
Figure 14.19 Lyophilization Services Market for Biopharmaceuticals in Rest of the World, Till 2035 (USD Billion)
Figure 15.1 Concluding Remarks: Overall Market Landscape
Figure 15.2 Concluding Remarks: Benchmark Analysis
Figure 15.3 Concluding Remarks: Partnership and Collaborations
Figure 15.4 Concluding Remarks: Recent Expansions
Figure 15.5 Concluding Remarks: Market Forecast

Product Code: RA100345

LYOPHILIZATION SERVICES MARKET: OVERVIEW

As per Roots Analysis, the global lyophilization services market is estimated to grow from USD 2.6 billion in the current year to USD 4.9 billion by 2035, at a CAGR of 6.3% during the forecast period, till 2035.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Biologic Lyophilized

Antibodies
Cells and Gene Therapies
Vaccines
Other Biologics

Type of Primary Packaging System

Vials
Syringes
Cartridges
Ampoules
Others

Key Geographies

North America
Europe
Asia-Pacific
Latin America
Middle East and North Africa

LYOPHILIZATION SERVICES MARKET: GROWTH AND TRENDS

Lyophilization is a drug stabilization technique that involves removing excess solvents, such as water, through freeze-drying while preserving the chemical properties of the substance. Notably, lyophilization utilizes specialized equipment, including laboratory freeze dryers, non-sterile freeze dryers, and sterilizable lyophilizers. It is worth highlighting that over the years, lyophilization has emerged as the preferred approach to achieve longer and commercially viable shelf lives, enabling stable and dry biopharmaceutical formulations. However, characterized by a rapidly growing pipeline of biosimilars and novel biologics, and the existing challenges associated with lyophilization of biotherapeutics, stakeholders are increasingly relying on service providers that offer multidisciplinary expertise in this domain.

In addition, several market leaders are accelerating their research for lyophilization technology advancements and innovations to improve working efficiency and achieve process control during the drying process. This has resulted in improved productivity and efficiency of the overall process. For instance, latest technologies, such as continuous freeze-drying systems and automated lyophilization systems, are encouraging industrial leaders to adopt these technologies and meet the customized lyophilization services requirements of clients.

LYOPHILIZATION SERVICES MARKET: KEY INSIGHTS

The report delves into the current state of the lyophilization services market and identifies potential growth opportunities within industry. Some key findings from the report include:

Presently, over 105 service providers claim to have the required expertise to offer lyophilization services for a variety of biotherapeutics, including proteins, antibodies, nucleic acids and cell / gene therapies.
The current market landscape is highly fragmented, featuring the presence of both new entrants and established players based in key geographical regions.
Leveraging their expertise, stakeholders are offering lyophilization services at different scales of operation; further, vials emerged as the preferred choice of primary packaging system for storing biologics.

In order to successfully navigate the evolving regulatory landscape, service providers are expanding their portfolios to cater to customized requests of their clients.
The growing interest in this domain is evident from the rise in partnership activity; in fact, the maximum number of collaborations related to lyophilization of biopharmaceuticals were signed in the past two years.
To keep pace with the growing demand, many companies have undertaken expansion initiatives, such as establishing new facilities or expanding their existing capabilities, to strengthen their service portfolio.
The market is expected to grow at a steady rate till 2035; the projected opportunity is anticipated to be well distributed across various types of biologic lyophilized, primary packaging systems and geographical regions.

LYOPHILIZATION SERVICES MARKET: KEY SEGMENTS

Antibodies Segment holds the Largest Share of the Lyophilization Services Market

Based on the type of biologics lyophilized, the market is segmented into antibodies, cell and gene therapies, vaccines, and other biologics. At present, the antibodies segment holds the maximum share of the global lyophilization services market. This trend is likely to remain the same in the coming years owing to the increasing demand for target-specific drugs for the treatment of a myriad of diseases.

By Type of Primary Packaging System, Syringes is the Fastest Growing Segment of the Global Lyophilization Services Market

Based on the type of primary packaging system, the market is segmented into vials, syringes, cartridges, ampoules, and others. At present, the vials segment holds the maximum share of the global lyophilization services market. However, the market for syringes segment is expected to grow at a higher CAGR during the forecast period owing to the growing demand for automated drug delivery injections and prefilled syringes.

North America Accounts for the Largest Share of the Market

Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa and Latin America. Currently, North America dominates the global lyophilization services market and accounts for the largest revenue share. Further, the market in Asia-Pacific is likely to grow at a higher CAGR in the coming future.

Example Players in the Lyophilization Services Market

Baxter BioPharma Solutions
CordenPharma
Coriolis Pharma
Curia
Emergent BioSolutions
LSNE Contract Manufacturing
Lyophilization Technology
Northway Biotech
ProJect Pharmaceutics
Vetter Pharma

LYOPHILIZATION SERVICES MARKET: RESEARCH COVERAGE

Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the global lyophilization services market, focusing on key market segments, including [A] type of biologic lyophilized, [B] type of primary packaging system and [C] key geographies.
Market Landscape: A comprehensive evaluation of the companies offering lyophilization services, based on several relevant parameters, such as [A] year of establishment, [B] company size, [C] location of headquarters, [D] the scale of operation, [E] regulatory certification / accreditation, [F] type of biologic lyophilized, [G] the process of lyophilization, [H] type of primary packaging system and [I] additional services offered by the firms.
Benchmark Analysis: A comprehensive benchmark analysis of various service providers segregated into three peer groups based on the location of their headquarters. Additionally, the companies were further distributed across key geographies, based on their employee count, into three categories, namely [A] small, [B] mid-sized and [C] large / very large, highlighting the top players in the lyophilization services market, based on their respective capabilities.
Company Profiles: In-depth profiles of key players that are currently engaged in offering lyophilization services for biopharmaceuticals, focusing on [A] overview of the company, [B] lyophilization service offerings for biopharmaceuticals, [C] dedicated facilities and [D] recent developments and an informed future outlook.
Partnerships and Collaborations: An insightful analysis of the deals inked by stakeholders in this domain, based on several parameters, such as [A] year of partnership, [B] type of partnership, [C] most active players (in terms of the number of partnerships signed) and [D] geographical distribution.
Recent Expansions: In-depth analysis of the various expansion initiatives undertaken by lyophilization service providers for biopharmaceuticals, based on several parameters, such as [A] year of expansion, [B] type of expansion, [C] company size, [D] location of headquarters, [E] location of expanded facility, [F] most active players (in terms of number of recent expansions) and [G] geographical distribution.
Survey Analysis: An insightful analysis presenting additional insights on lyophilization services offered for biopharmaceuticals, based on several parameters, such as [A] type of biologic lyophilized, [B] type of primary packaging system, [C] scale of operation, [D] availability of lyophilization cycle development / optimization capabilities and [E] location of a dedicated manufacturing facility for lyophilization.
Case Study 1: A detailed discussion on lyophilization cycle development and optimization services, highlighting the important parameters and techniques required for these processes.
Case Study 2: A comprehensive discussion on the alternative approaches to the lyophilization process, such as [A] spray drying, [B] spray freeze dryer, [C] atmospheric spray freeze dryer, and [D] vacuum foam drying.

KEY QUESTIONS ANSWERED IN THIS REPORT

How many companies are currently engaged in this market?
Which are the leading companies in this market?
What factors are likely to influence the evolution of this market?
What is the current and future market size?
What is the CAGR of this market?
How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

Complimentary PPT Insights Packs
Complimentary Excel Data Packs for all Analytical Modules in the Report
15% Free Content Customization
Detailed Report Walkthrough Session with Research Team
Free Updated report if the report is 6-12 months old or older

1. PREFACE

1.1. Scope of the Report
1.2. Research Methodology
- 1.2.1. Research Assumptions
- 1.2.2. Project Methodology
- 1.2.3. Forecast Methodology
- 1.2.4. Robust Quality Control
- 1.2.5. Key Considerations
  - 1.2.5.1. Demographics
  - 1.2.5.2. Economic Factors
  - 1.2.5.3. Government Regulations
  - 1.2.5.4. Supply Chain
  - 1.2.5.5. COVID Impact / Related Factors
  - 1.2.5.6. Market Access
  - 1.2.5.7. Healthcare Policies
  - 1.2.5.8. Industry Consolidation
1.3 Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

3.1. Chapter Overview
3.2. Overview of Lyophilization
- 3.2.1. Historical Evolution
- 3.2.2. Underlying Principles
- 3.2.3. Advantages and Disadvantages
3.3. Lyophilization of Biopharmaceuticals
- 3.3.1. Need for Lyophilization of Biopharmaceuticals
- 3.3.2. Lyophilization Process
  - 3.3.2.1. Formulation and Filling
  - 3.3.2.2. Freezing
  - 3.3.2.3. Primary Drying
  - 3.3.2.4. Secondary Drying
3.4. Lyophilizer and its Key Components
3.5. Primary Packaging Systems Used for Lyophilization of Biopharmaceuticals
3.6. Lyophilization Cycle Development and Optimization
3.7. Concluding Remarks

4. MARKET LANDSCAPE

4.1. Chapter Overview
4.2. Lyophilization Service Providers for Biopharmaceuticals: Overall Market Landscape
- 4.2.1. Analysis by Year of Establishment
- 4.2.2. Analysis by Company Size
- 4.2.3. Analysis by Location of Headquarters
- 4.2.4. Analysis by Scale of Operation
- 4.2.5. Analysis by Regulatory Certification / Accreditation
- 4.2.6. Analysis by Type of Biologic Lyophilized
- 4.2.7. Analysis by Process of Lyophilization
- 4.2.8. Analysis by Type of Primary Packaging System
- 4.2.9. Analysis by Additional Services Offered

5. BENCHMARK ANALYSIS

5.1. Chapter Overview
5.2. Methodology
5.3. Benchmark Analysis: Peer Groups
- 5.3.1. Benchmark Analysis: North America (Peer Group I)
- 5.3.2. Benchmark Analysis: North America (Peer Group II)
- 5.3.3. Benchmark Analysis: North America (Peer Group III)
- 5.3.4. Benchmark Analysis: Europe (Peer Group IV)
- 5.3.5. Benchmark Analysis: Europe (Peer Group V)
- 5.3.6. Benchmark Analysis: Europe (Peer Group VI)
- 5.3.7. Benchmark Analysis: Asia Pacific and Rest of the World (Peer Group VII)
- 5.3.8. Benchmark Analysis: Asia Pacific and Rest of the World (Peer Group VIII)

6. COMPANY PROFILES: LYOPHILIZATION SERVICE PROVIDERS FOR BIOPHARMACEUTICALS IN NORTH AMERICA

6.1. Chapter Overview
6.2. Baxter BioPharma Solutions
- 6.2.1. Company Overview
- 6.2.2. Lyophilization Service Offerings for Biopharmaceuticals
- 6.2.3. Dedicated Biopharmaceutical Lyophilization Facilities
- 6.2.4. Recent Developments and Future Outlook
6.3. Curia
- 6.3.1. Company Overview
- 6.3.2. Lyophilization Service Offerings for Biopharmaceuticals
- 6.3.3. Dedicated Biopharmaceutical Lyophilization Facilities
- 6.3.4. Recent Developments and Future Outlook
6.4. Emergent BioSolutions
- 6.4.1. Company Overview
- 6.4.2. Lyophilization Service Offerings for Biopharmaceuticals
- 6.4.3. Dedicated Biopharmaceutical Lyophilization Facilities
- 6.4.4. Recent Developments and Future Outlook
6.5. LSNE Contract Manufacturing
- 6.5.1. Company Overview
- 6.5.2. Lyophilization Service Offerings for Biopharmaceuticals
- 6.5.3. Dedicated Biopharmaceutical Lyophilization Facilities
- 6.5.4. Recent Developments and Future Outlook
6.6. Lyophilization Technology
- 6.6.1. Company Overview
- 6.6.2. Lyophilization Service Offerings for Biopharmaceuticals
- 6.6.3. Dedicated Biopharmaceutical Lyophilization Facilities
- 6.6.4. Recent Developments and Future Outlook

7. COMPANY PROFILES: LYOPHILIZATION SERVICE PROVIDERS FOR BIOPHARMACEUTICALS IN EUROPE

7.1. Chapter Overview
7.2. CordenPharma
- 7.2.1. Company Overview
- 7.2.2. Lyophilization Service Offerings for Biopharmaceuticals
- 7.2.3. Dedicated Biopharmaceutical Lyophilization Facilities
- 7.2.4. Recent Developments and Future Outlook
7.3. Coriolis Pharma
- 7.3.1. Company Overview
- 7.3.2. Lyophilization Service Offerings for Biopharmaceuticals
- 7.3.3. Dedicated Biopharmaceutical Lyophilization Facilities
- 7.3.4. Recent Developments and Future Outlook
7.4. Northway Biotech
- 7.4.1. Company Overview
- 7.4.2. Lyophilization Service Offerings for Biopharmaceuticals
- 7.4.3. Dedicated Biopharmaceutical Lyophilization Facilities
- 7.4.4. Recent Developments and Future Outlook
7.5. ProJect Pharmaceutics
- 7.5.1. Company Overview
- 7.5.2. Lyophilization Service Offerings for Biopharmaceuticals
- 7.5.3. Dedicated Biopharmaceutical Lyophilization Facilities
- 7.5.4. Recent Developments and Future Outlook
7.6. Vetter Pharma
- 7.6.1. Company Overview
- 7.6.2. Lyophilization Service Offerings for Biopharmaceuticals
- 7.6.3. Dedicated Biopharmaceutical Lyophilization Facilities
- 7.6.4. Recent Developments and Future Outlook

8. COMPANY PROFILES: LYOPHILIZATION SERVICE PROVIDERS FOR BIOPHARMACEUTICALS IN ASIA PACIFIC

8.1. Chapter Overview
8.2. BioZed Engineering
- 8.2.1. Company Overview
- 8.2.2. Lyophilization Service Offerings for Biopharmaceuticals
- 8.2.3. Dedicated Biopharmaceutical Lyophilization Facilities
- 8.2.4. Recent Developments and Future Outlook
8.3. CinnaGen
- 8.3.1. Company Overview
- 8.3.2. Lyophilization Service Offerings for Biopharmaceuticals
- 8.3.3. Dedicated Biopharmaceutical Lyophilization Facilities
- 8.3.4. Recent Developments and Future Outlook
8.4. MabPlex
- 8.4.1. Company Overview
- 8.4.2. Lyophilization Service Offerings for Biopharmaceuticals
- 8.4.3. Dedicated Biopharmaceutical Lyophilization Facilities
- 8.4.4. Recent Developments and Future Outlook
8.5. Samsung Biologics
- 8.5.1. Company Overview
- 8.5.2. Lyophilization Service Offerings for Biopharmaceuticals
- 8.5.3. Dedicated Biopharmaceutical Lyophilization Facilities
- 8.5.4. Recent Developments and Future Outlook
8.6. WuXi Biologics
- 8.6.1. Company Overview
- 8.6.2. Lyophilization Service Offerings for Biopharmaceuticals
- 8.6.3. Dedicated Biopharmaceutical Lyophilization Facilities
- 8.6.4. Recent Developments and Future Outlook

9. PARTNERSHIPS AND COLLABORATIONS

9.1. Chapter Overview
9.2. Partnership Models
9.3. Lyophilization Services for Biopharmaceuticals: List of Partnerships and Collaborations
- 9.3.1. Analysis by Year of Partnership
- 9.3.2. Analysis by Type of Partnership
- 9.3.3. Analysis by Year and Type of Partnership
- 9.3.4. Most Active Players: Analysis by Number of Partnerships
- 9.3.5. Analysis by Geography
  - 9.3.5.1. Intercontinental and Intracontinental Deals
  - 9.3.5.2. International and Local Deals

10. RECENT EXPANSIONS

10.1. Chapter Overview
10.2. Lyophilization Services Market for Biopharmaceuticals: List of Recent Expansions
- 10.2.1. Analysis by Year of Expansion
- 10.2.2. Analysis by Type of Expansion
- 10.2.3. Analysis by Year and Type of Expansion
- 10.2.4. Analysis by Company Size and Location of Headquarters
- 10.2.5. Analysis by Location of Expanded Facility
- 10.2.6. Active Players: Analysis by Number of Recent Expansions
- 10.2.7. Analysis by Geography

11. SURVEY ANALYSIS

11.1. Chapter Overview
11.2. Lyophilization Services Market for Biopharmaceuticals: List of Participating Companies
- 11.2.1. Analysis by Seniority Level of Respondents
- 11.2.2. Analysis by Type of Biologic Lyophilized
- 11.2.3. Analysis by Type of Primary Packaging System
- 11.2.4. Analysis by Scale of Operation
- 11.2.5. Analysis by Additional Services Offered
- 11.2.6. Analysis by Location of Lyophilization Facility
- 11.2.7. Analysis by Share of Lyophilization Operations Outsourced
- 11.2.8. Analysis by Likely Market Size
- 11.2.9. Analysis of Likely Market Share by Type of Biologic Lyophilized
- 11.2.10. Analysis of Likely Market Share by Geography

12. CASE STUDY I: LYOPHILIZATION CYCLE DEVELOPMENT AND OPTIMIZATION

12.1. Chapter Overview
12.2. Lyophilization Cycle Development
12.3. Lyophilization Cycle Optimization
12.4. Lyophilization Cycle Development and Optimization: List of Service Providers
- 12.4.1. Analysis by Company Size
- 12.4.2. Analysis by Location of Headquarters
- 12.4.3. Analysis by Type of Service Offered
- 12.4.4. Lyophilization Cycle Development and Optimization Service Providers: Company Snapshots

13. CASE STUDY II: ALTERNATIVE APPROACHES TO LYOPHILIZATION

13.1. Chapter Overview
13.2. Alternative Approaches to Lyophilization
- 13.2.1. Spray Drying
  - 13.2.1.1. Spray Drying Process
  - 13.2.1.2. Applications of Spray Drying
  - 13.2.1.3. Spray Drying of Biopharmaceuticals
  - 13.2.1.4. Spray Drying Service Providers for Biopharmaceuticals
  - 13.2.1.5. Comparison of Lyophilization and Spray Drying
- 13.2.2. Spray Freeze Drying
- 13.2.3. Atmospheric Spray Freeze Drying
- 13.2.4. Vacuum Foam Drying

14. MARKET FORECAST AND OPPORTUNITY ANALYSIS

14.1. Chapter Overview
14.2. Forecast Methodology and Key Assumptions
14.3. Global Lyophilization Services Market for Biopharmaceuticals, Till 2035
14.4. Lyophilization Services Market for Biopharmaceuticals: Distribution by Type of Biologic Lyophilized
- 14.4.1. Lyophilization Services Market for Antibodies, Till 2035
- 14.4.2. Lyophilization Services Market for Cell and Gene Therapies, Till 2035
- 14.4.3. Lyophilization Services Market for Vaccines, Till 2035
- 14.4.4. Lyophilization Services Market for Other Biologics, Till 2035
14.5. Lyophilization Services Market for Biopharmaceuticals: Distribution by Type of Primary Packaging System
- 14.5.1. Lyophilization Services Market for Biopharmaceuticals for Vials, Till 2035
- 14.5.2. Lyophilization Services Market for Biopharmaceuticals for Syringes, Till 2035
- 14.5.3. Lyophilization Services Market for Biopharmaceuticals for Cartridges, Till 2035
- 14.5.4. Lyophilization Services Market for Biopharmaceuticals for Ampoules, Till 2035
- 14.5.5. Lyophilization Services Market for Biopharmaceuticals for Other Primary Packaging Systems, Till 2035
14.6. Lyophilization Services Market for Biopharmaceuticals: Distribution by Geography
- 14.6.1. Lyophilization Services Market for Biopharmaceuticals in North America, Till 2035
- 14.6.2. Lyophilization Services Market for Biopharmaceuticals in Europe, Till 2035
- 14.6.3. Lyophilization Services Market for Biopharmaceuticals in Asia Pacific, Till 2035
- 14.6.4. Lyophilization Services Market for Biopharmaceuticals in Middle East and North Africa, Till 2035
- 14.6.5. Lyophilization Services Market for Biopharmaceuticals in Latin America, Till 2035
- 14.6.6. Lyophilization Services Market for Biopharmaceuticals in Rest of the World, Till 2035

15. CONCLUDING REMARKS

16. EXECUTIVE INSIGHTS

16.1. Chapter Overview
16.2. Company A
- 16.2.1. Company Snapshot
- 16.2.2. Interview Transcript
16.3. Company B
- 16.3.1. Company Snapshot
- 16.3.2. Interview Transcript
16.4. Company C
- 16.4.1. Company Snapshot
- 16.4.2. Interview Transcript
16.5. Company D
- 16.5.1. Company Snapshot
- 16.5.2. Interview Transcript
16.6. Company E
- 16.6.1. Company Snapshot
- 16.6.2. Interview Transcript
16.7. Company F
- 16.7.1. Company Snapshot
- 16.7.2. Interview Transcript
16.8. Company G
- 16.8.1. Company Snapshot
- 16.8.2. Interview Transcript
16.9. Company H
- 16.9.1. Company Snapshot
- 16.9.2. Interview Transcript
16.10. Company I
- 16.10.1. Company Snapshot
- 16.10.2. Interview Transcript
16.11. Company J
- 16.11.1. Company Snapshot
- 16.11.2. Interview Transcript

凍結乾燥サービス市場：業界動向と世界の予測 - 凍結乾燥される生物製剤タイプ別、一次包装システムタイプ別、主要地域別

Lyophilization Services Market : Industry Trends and Global Forecasts - Distribution by Type of Biologic Lyophilized, Type of Primary Packaging System and Key Geographies

凍結乾燥サービス市場：概要

凍結乾燥サービス市場：成長と動向

凍結乾燥サービス市場：主要インサイト

凍結乾燥サービス市場：主要セグメント

凍結乾燥サービス市場における参入企業例

目次

第1章 序文

第2章 エグゼクティブサマリー

第3章 イントロダクション

第4章 市場情勢

第5章 ベンチマーク分析

第6章 企業プロファイル：北米における生物製剤の凍結乾燥サービスプロバイダー

第7章 企業プロファイル：欧州における生物製剤の凍結乾燥サービスプロバイダー

第8章 企業プロファイル：アジア太平洋における生物製剤の凍結乾燥サービスプロバイダー

第9章 パートナーシップとコラボレーション

第10章 最近の拡張

第11章 調査分析

第12章 ケーススタディI：凍結乾燥サイクルの開発と最適化

第13章 ケーススタディII：凍結乾燥の代替アプローチ

第14章 市場予測と機会分析

第15章 結論

第16章 エグゼクティブ洞察

第17章 付録1：表形式データ

第18章 付録2：企業・団体一覧

List of Tables

List of Figures

LYOPHILIZATION SERVICES MARKET: OVERVIEW

LYOPHILIZATION SERVICES MARKET: GROWTH AND TRENDS

LYOPHILIZATION SERVICES MARKET: KEY INSIGHTS

LYOPHILIZATION SERVICES MARKET: KEY SEGMENTS

Example Players in the Lyophilization Services Market

LYOPHILIZATION SERVICES MARKET: RESEARCH COVERAGE

KEY QUESTIONS ANSWERED IN THIS REPORT

REASONS TO BUY THIS REPORT

ADDITIONAL BENEFITS

TABLE OF CONTENTS

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

4. MARKET LANDSCAPE

5. BENCHMARK ANALYSIS

6. COMPANY PROFILES: LYOPHILIZATION SERVICE PROVIDERS FOR BIOPHARMACEUTICALS IN NORTH AMERICA

7. COMPANY PROFILES: LYOPHILIZATION SERVICE PROVIDERS FOR BIOPHARMACEUTICALS IN EUROPE

8. COMPANY PROFILES: LYOPHILIZATION SERVICE PROVIDERS FOR BIOPHARMACEUTICALS IN ASIA PACIFIC

9. PARTNERSHIPS AND COLLABORATIONS

10. RECENT EXPANSIONS

11. SURVEY ANALYSIS

12. CASE STUDY I: LYOPHILIZATION CYCLE DEVELOPMENT AND OPTIMIZATION

13. CASE STUDY II: ALTERNATIVE APPROACHES TO LYOPHILIZATION

14. MARKET FORECAST AND OPPORTUNITY ANALYSIS

15. CONCLUDING REMARKS

16. EXECUTIVE INSIGHTS

17. APPENDIX 1: TABULATED DATA

18. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

第1章序文

第2章エグゼクティブサマリー

第3章イントロダクション

第4章市場情勢

第5章ベンチマーク分析

第6章企業プロファイル：北米における生物製剤の凍結乾燥サービスプロバイダー

第7章企業プロファイル：欧州における生物製剤の凍結乾燥サービスプロバイダー

第8章企業プロファイル：アジア太平洋における生物製剤の凍結乾燥サービスプロバイダー

第9章パートナーシップとコラボレーション

第10章最近の拡張

第11章調査分析

第12章ケーススタディI：凍結乾燥サイクルの開発と最適化

第13章ケーススタディII：凍結乾燥の代替アプローチ

第14章市場予測と機会分析

第15章結論

第16章エグゼクティブ洞察

第17章付録1：表形式データ

第18章付録2：企業・団体一覧